Brief: Adocia Starts First-In-Human Clinical Study Of BioChaperone Pramlintide Insulin

Adocia SA

16/04/2018 06:52

April 16 (Reuters) - ADOCIA SA  ADOC.PA :
    * ADOCIA INITIATES FIRST-IN-HUMAN CLINICAL STUDY OF
BIOCHAPERONE®
PRAMLINTIDE INSULIN IN PEOPLE WITH TYPE 1 DIABETES
    * STUDY IS EXPECTED TO BE COMPLETED IN Q3 2018

Source text for Eikon:  ID:nBwbTnMqma 
Further company coverage:  ADOC.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 59 772 0920;))